S. Akar Et Al. , "β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene," Molecular Biology Reports , vol.49, no.8, pp.7409-7415, 2022
Akar, S. Et Al. 2022. β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene. Molecular Biology Reports , vol.49, no.8 , 7409-7415.
Akar, S., ALTUNTAŞ, H., & HAMURCU, Z., (2022). β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene. Molecular Biology Reports , vol.49, no.8, 7409-7415.
Akar, Sakine, HAMİYET ALTUNTAŞ, And ZÜHAL HAMURCU. "β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene," Molecular Biology Reports , vol.49, no.8, 7409-7415, 2022
Akar, Sakine Et Al. "β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene." Molecular Biology Reports , vol.49, no.8, pp.7409-7415, 2022
Akar, S. ALTUNTAŞ, H. And HAMURCU, Z. (2022) . "β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene." Molecular Biology Reports , vol.49, no.8, pp.7409-7415.
@article{article, author={Sakine Akar Et Al. }, title={β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene}, journal={Molecular Biology Reports}, year=2022, pages={7409-7415} }